Pharmacoepidemiology and Drug Safety (PDS) PDS is the official journal of ISPE; PDS is a MEDLINE and ISI listed journal. Guest editorials, commentaries and invited reviews encompassing scientific, medical, statistical and legal aspects of pharmacoepidemiology and post-marketing surveillance of drug safety.

A pharmacoepidemiologist is a healthcare researcher that works with pharmaceuticals and disease research. This type of professional looks at the population as a whole and investigates issues like risk factors and behavior to figure out how medicine and healthcare can help eliminate and treat diseases.

Origin of the word pharmacoepidemiology The term was first coined in 1984 in England [15], and it would indeed be inelegant not to quote in extenso the words of one of the fathers of pharmacoepidemiology: Prof. David H Lawson: “The centre for medicines research held an one-day meeting …

Pharmacodynamics (PD) is the study of the biochemical and physiologic effects of drugs (especially pharmaceutical drugs). In particular, pharmacodynamics is the study of how a drug affects an organism, whereas pharmacokinetics is the study of how the organism affects the drug.

Pharmacovigilance is considered to be one of the best career option for life science and pharmacy graduates. It mainly deals with reporting and analysing of medicine side effects and ensure drugs in the market are safe and secured.

Employees who knows Pharmacovigilance earn an average of ₹21lakhs, mostly ranging from ₹10lakhs per year to ₹50lakhs per year based on 202 profiles. The top 10% of employees earn more than ₹30lakhs per year.

Pharmacoepidemiology is the study of the utilization and effects of drugs in large numbers of people; it provides an estimate of the probability of beneficial effects of a drug in a population and the probability of adverse effects. It can be called a bridge science spanning both clinical pharmacology and epidemiology.

The main difference between pharmacokinetics and pharmacodynamics is that pharmacokinetics (PK) is defined as the movement of drugs through the body, whereas pharmacodynamics (PD) is defined as the body’s biological response to drugs.

In simple words, pharmacokinetics is ‘what the body does to the drug’. Pharmacodynamics describes the intensity of a drug effect in relation to its concentration in a body fluid, usually at the site of drug action. It can be simplified to ‘what the drug does to the body’.

This certificate program will provide learners with core knowledge of pharmacoepidemiology and drug safety, as well as insights from these fields that can inform the work of policy-makers, patients, clinicians and payers seeking to improve the quality and safety of medication use.

The Program in Pharmacoepidemiology at the Harvard T.H. Chan School of Public Health was established to promote excellence in pharmacoepidemiology and is the world’s oldest and most comprehensive academic program in the field.

Since pharmacoepidemiology employs quantitative methods, students will learn to measure phenomena such as drug utilization, its quality, and sequelae on patient morbidity or mortality on a population level. Read selected publications from our faculty, or catch up on the latest News Release to learn more about pharmacoepidemiology research at UF.

Pharmacoepidemiology is one of the oldest and largest areas of research and training in POP. It can be defined as the application of epidemiologic reasons, methods and knowledge to the study of uses and effects of drugs in human populations.